IRCT201403101836N7已完成2 期
Metformin and pioglitazone in women with polycystic ovary syndrome
Shahid Sadoughi University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 40 years（—）
- 性别
- Female
入选标准
- •age between 18 to 40 years old; diagnosed PCOS by AES (Androgen excess soiciety2006) criteria include:
- •1. Oligo or anovulation 2. Clinical or biochemical hyperandrogenism and rejection any other reasen cause to hyperandrogenism. Exclusion criteria: pregnancy and lactation; impaired liver and renal function tests; thyroid disorder; hyperprolactinemia; adrenal disorders; patient on estrogen and progesterone pills; the presence of type 1 and type 2 diabetes mellitus; late-onset congenital adrenal hyperplasia, and Cushing’s syndrome; none of the women had been taking clomiphene citrate, oral contraceptives, antiandrogens, insulin, minoxidil, phenytoin, cyclosporine, or drugs to control their appetite, lipid profile, during the previous 3 months and any severe systemic disease.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effects of metformin and pioglitazone in polycystic ovarian syndromePolycystic ovarian syndrome.Endocrine nutritional and metabolic diseasesIRCT201008094179N3Vice-chancellor for research, Kermanshah University of Medical Science56
已完成
不适用
The use of metformin in patients with polycystic ovarian syndrome requiring treatment with in vitro fertilisation (IVF)rological and Genital Diseases: Polycystic ovarian syndrome (PCOS)Urological and Genital DiseasesPolycystic ovarian syndrome (PCOS)ISRCTN47219228Department of Health (UK)100
进行中（未招募）
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyEUCTR2007-006706-14-ATTakeda Pharma GmbH200
进行中（未招募）
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyDiabetes mellitus type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2007-006706-14-DETakeda Pharma GmbH
尚未招募
4 期
A randomized trial of Metformin in autosomal dominant polycystic kidney disease for reducing rate of decline of kidney functioCTRI/2024/08/072241Indian Council of Medical Research